|
wisconsin
Quote:
Originally posted by sgtclub
I agree with most of this, but would agrue that the recoupment during the monopoloy period for R&D costs and the 100 failures is the most efficient way for the company to recoup those costs, realizing that the pricing may not be the most efficient for the consumers if there are no other alternative drugs to chose from. Are you are saying that the company could charge significantly less, still recoup costs, and make a competitive profit? If so, I would be skeptical.
|
Why is it so important that we ensure that pharma earns big (or "competitive"*) profits?
* "competitive" with what?
__________________
“It was fortunate that so few men acted according to moral principle, because it was so easy to get principles wrong, and a determined person acting on mistaken principles could really do some damage." - Larissa MacFarquhar
|
Threaded Mode